130 related articles for article (PubMed ID: 32929607)
1. CADM1 enhances intestinal barrier function in a rat model of mild inflammatory bowel disease by inhibiting the STAT3 signaling pathway.
Sun S; Liu W; Li Y
J Bioenerg Biomembr; 2020 Oct; 52(5):343-354. PubMed ID: 32929607
[TBL] [Abstract][Full Text] [Related]
2. Tong-Xie-Yao-Fang improves intestinal permeability in diarrhoea-predominant irritable bowel syndrome rats by inhibiting the NF-κB and notch signalling pathways.
Hou Q; Huang Y; Zhu Z; Liao L; Chen X; Han Q; Liu F
BMC Complement Altern Med; 2019 Nov; 19(1):337. PubMed ID: 31775739
[TBL] [Abstract][Full Text] [Related]
3. miR-21 enhances cardiac fibrotic remodeling and fibroblast proliferation via CADM1/STAT3 pathway.
Cao W; Shi P; Ge JJ
BMC Cardiovasc Disord; 2017 Mar; 17(1):88. PubMed ID: 28335740
[TBL] [Abstract][Full Text] [Related]
4. [Curcumin mediates IL-6/STAT3 signaling pathway to repair intestinal mucosal injury induced by 5-FU chemotherapy for colon cancer].
Xu L; Wang X; Wang XY; Yao QH; Chen YB
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(3):670-677. PubMed ID: 33645034
[TBL] [Abstract][Full Text] [Related]
5. Ginger relieves intestinal hypersensitivity of diarrhea predominant irritable bowel syndrome by inhibiting proinflammatory reaction.
Zhang C; Huang Y; Li P; Chen X; Liu F; Hou Q
BMC Complement Med Ther; 2020 Sep; 20(1):279. PubMed ID: 32928188
[TBL] [Abstract][Full Text] [Related]
6. [Protective role of green tea polyphenols in intestinal mucosal barrier function of mice with colitis induced by TNBS through inhibiting JAK2/STAT3 pathway].
Xi J; Ge S; Zuo L; Zhu Y; Wang L; Xie Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Mar; 34(3):237-241. PubMed ID: 29773105
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of microRNA-495 improves the intestinal mucosal barrier function by targeting STAT3 via inhibition of the JAK/STAT3 signaling pathway in a mouse model of ulcerative colitis.
Chu XQ; Wang J; Chen GX; Zhang GQ; Zhang DY; Cai YY
Pathol Res Pract; 2018 Jan; 214(1):151-162. PubMed ID: 29129493
[TBL] [Abstract][Full Text] [Related]
8. Momordica charantia polysaccharides alleviate diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and barrier via NF-κB pathway.
Ji S; Zhang Q
Allergol Immunopathol (Madr); 2022; 50(3):62-70. PubMed ID: 35527657
[TBL] [Abstract][Full Text] [Related]
9. [Effect of electroacupuncture on intestinal epithelial mucosal barrier function in rats with diarrhea-predominant irritable bowel syndrome].
Yao JP; Zhao Y; Chen Y; Chen LP; Feng XM; Li Y; Zhou SY
Zhen Ci Yan Jiu; 2020 May; 45(5):357-62. PubMed ID: 32447848
[TBL] [Abstract][Full Text] [Related]
10. CADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity.
Vallath S; Sage EK; Kolluri KK; Lourenco SN; Teixeira VS; Chimalapati S; George PJ; Janes SM; Giangreco A
Sci Rep; 2016 Apr; 6():24006. PubMed ID: 27035095
[TBL] [Abstract][Full Text] [Related]
11. Syndecan-1 Acts in Synergy with Tight Junction Through Stat3 Signaling to Maintain Intestinal Mucosal Barrier and Prevent Bacterial Translocation.
Wang Z; Li R; Tan J; Peng L; Wang P; Liu J; Xiong H; Jiang B; Chen Y
Inflamm Bowel Dis; 2015 Aug; 21(8):1894-907. PubMed ID: 25970544
[TBL] [Abstract][Full Text] [Related]
12. Metformin prevents colonic barrier dysfunction by inhibiting mast cell activation in maternal separation-induced IBS-like rats.
Li Y; Yang T; Yao Q; Li S; Fang E; Li Y; Liu C; Li W
Neurogastroenterol Motil; 2019 May; 31(5):e13556. PubMed ID: 30740845
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA 29 targets nuclear factor-κB-repressing factor and Claudin 1 to increase intestinal permeability.
Zhou Q; Costinean S; Croce CM; Brasier AR; Merwat S; Larson SA; Basra S; Verne GN
Gastroenterology; 2015 Jan; 148(1):158-169.e8. PubMed ID: 25277410
[TBL] [Abstract][Full Text] [Related]
14. MiR-144 Increases Intestinal Permeability in IBS-D Rats by Targeting OCLN and ZO1.
Hou Q; Huang Y; Zhu S; Li P; Chen X; Hou Z; Liu F
Cell Physiol Biochem; 2017; 44(6):2256-2268. PubMed ID: 29258088
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of two laboratory model methods for diarrheal irritable bowel syndrome.
Chen Q; Zhang H; Sun CY; He QY; Zhang RR; Luo BF; Zhou ZH; Chen XF
Mol Med; 2023 Jan; 29(1):5. PubMed ID: 36635623
[TBL] [Abstract][Full Text] [Related]
16. Ghrelin inhibits inflammatory response and apoptosis of myocardial injury in septic rats through JAK/STAT signaling pathway.
Jin L; Cai CL; Lang XL; Li BL
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11740-11746. PubMed ID: 33275272
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of miRNA-29a regulates intestinal barrier function in diarrhea-predominant irritable bowel syndrome by upregulating ZO-1 and CLDN1.
Zhu H; Xiao X; Shi Y; Wu Y; Huang Y; Li D; Xiong F; He G; Chai Y; Tang H
Exp Ther Med; 2020 Dec; 20(6):155. PubMed ID: 33093893
[TBL] [Abstract][Full Text] [Related]
18. Fushen Granule, A Traditional Chinese Medicine, ameliorates intestinal mucosal dysfunction in peritoneal dialysis rat model by regulating p38MAPK signaling pathway.
Jiang C; Lin W; Wang L; Lv Y; Song Y; Chen X; Yang H
J Ethnopharmacol; 2020 Apr; 251():112501. PubMed ID: 31877365
[TBL] [Abstract][Full Text] [Related]
19. MiR-21 inhibitor improves locomotor function recovery by inhibiting IL-6R/JAK-STAT pathway-mediated inflammation after spinal cord injury in model of rat.
Ning SL; Zhu H; Shao J; Liu YC; Lan J; Miao J
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):433-440. PubMed ID: 30720148
[TBL] [Abstract][Full Text] [Related]
20. Chang'an II Decoction ( II )-Containing Serum Ameliorates Tumor Necrosis Factor-α-Induced Intestinal Epithelial Barrier Dysfunction via MLCK-MLC Signaling Pathway in Rats.
Chen T; Yin XL; Kang N; Wang XG; Li BS; Ji HJ; Zhang YQ; Bian LQ; Zhang BH; Wang FY; Tang XD
Chin J Integr Med; 2020 Oct; 26(10):745-753. PubMed ID: 31768870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
